Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 403 Forbidden error page was added, including the HTML snippet and a 403 title, indicating that access to the study record is blocked and a Home link is provided in the footer. This reflects an access-control issue rather than a content update.SummaryDifference0.5%

- Check19 days agoChange DetectedA revision tag (Revision: v3.7.0) was added, and a large set of metadata terms and PubMed-related sections were removed from the record, affecting auxiliary information and indexing rather than the study's essential details.SummaryDifference18%

- Check40 days agoChange DetectedThe study record adds a U.S. NIH grant/contract identifier and updates the page revision to v3.6.6. The previous revision tag v3.6.5 is removed.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling a minor update to the study page. This update likely affects metadata or formatting without changing core study details.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page shows an updated revision tag from v3.6.3 to v3.6.4, indicating a new version of the study record.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page now shows a new revision tag v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page's metadata or backend content rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.